Objective:To explore the early diagnostic value of combined detection of serum chitinase protein 40 (YKL-40), galectin-3 (Gal-3), and regulated upon activation normal T cell expressed and secreted (RANTES) for refractory mycoplasma pneumoniae pneumonia (RMPP) in children.Methods:One hundred and twenty-six children with RMPP (RMPP group), 126 children with global mycoplasma pneumoniae pneumonia (GMPP) (GMPP group), and 126 healthy children who underwent physical check up (control group) in the Affiliated Hospital of Jining Medical College from June 2022 to June 2024 were retrospectively selected. The serum levels of YKL-40, Gal-3 and RANTES were compared. Multivariate Logistic regression was used to analyze the independent influencing factors of RMPP. Receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of serum YKL-40, Gal-3 and RANTES levels for RMPP.Results:Compared with the control group, the serum YKL-40, Gal-3 and RANTES levels in the RMPP and GMPP groups were obviously higher: (42.19 ± 4.94) and (37.68 ± 4.25) μg/L vs. (26.73 ± 3.31) μg/L, (12.24 ± 2.89) and (8.87 ± 2.56) ng/L vs. (3.92 ± 1.27) ng/L, (33.82 ± 3.86) and (29.28 ± 3.72) μg/L vs. (21.34 ± 2.79) μg/L, with statistical significance ( P<0.05). Compared with the GMPP group, the serum YKL-40, Gal-3 and RANTES levels in the RMPP group were obviously higher ( P<0.05). Compared with the GMPP group, there was no statistically obvious difference in age, gender, body weight, duration of fever and atelectasis in the RMPP group ( P>0.05), however, the levels of C-reactive protein (CRP), procalcitonin (PCT), and the proportions of pleural effusion and lung consolidation were obviously higher in the RMPP group: (22.45 ± 4.21) mg/L vs. (18.69 ± 3.56) mg/L, (0.18 ± 0.04) μg/L vs. (0.15 ± 0.03) μg/L, 31.75% (40/126) vs. 17.46% (22/126), 38.89% (49/126) vs. 25.40% (32/126), P<0.05. CRP, PCT, pleural effusion, pulmonary consolidation, YKL-40, Gal-3 and RANTES were all independent influencing factors of RMPP ( P<0.05). The areas under the curve (AUC) of serum YKL-40, Gal-3 and RANTES levels for diagnosing RMPP in children were 0.769, 0.833 and 0.825, respectively. The AUC of the combined diagnosis of YKL-40, Gal-3 and RANTES was 0.923, which was obviously higher than that of the single indicator diagnosis ( Z = 5.373, 3.677 and 4.191; P<0.01). The sensitivity of the three combined diagnosis was 73.81%, and the specificity was 92.86%. Conclusions:Serum YKL-40, Gal-3 and RANTES levels are obviously elevated in patients with RMPP, and all of which are influencing factors of RMPP. The combination of the three has high diagnostic value for RMPP.

Objective:To investigate the serum level of soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients with multiple myeloma (MM) and its effect on the therapeutic effect of daletumab.Methods:A total of 126 MM patients admitted to the Affiliated Hospital of Jining Medical College from June 2019 to June 2021 were retrospectively selected as the observation group, and 120 healthy subjects in the same period were selected as the control group. The observation group was treated with daletumab. The level of sVCAM-1 in the observation group and the control group was compared, and the relationship between serum sVCAM-1 level and clinicopathological features, different Durie-Salmon (DS) stages, different International Staging System(ISS) stages and treatment outcome of MM patients were analyzed.Results:The serum level of sVCAM-1 in the observation group was higher than that in the control group: (797.69 ± 119.73) μg/L vs. (210.55 ± 73.77) μg/L, there was statistical difference ( P<0.01). There were no statistical differences in serum sVCAM-1 level among MM patients with different sex, body mass index, blood calcium, serum albumin, hemoglobin, lactate dehydrogenase and diagnostic type ( P>0.05). The serum level of sVCAM-1 in MM patients DS stage Ⅰ, Ⅱ and Ⅲ were (649.29 ± 101.02), (694.36 ± 109.88) and (729.66 ± 120.44) μg/L, there was statistical difference ( F = 5.12, P<0.01). The serum level of sVCAM-1 in MM patients with ISS stage Ⅰ, Ⅱ and Ⅲ were (648.73 ± 99.77), (701.05 ± 107.83) and (765.82 ± 111.07) μg/L, there was statistical difference ( F = 11.46, P<0.01). After treatment, the serum level of sVCAM-1 in MM patients with complete remission, partial remission and relapse were (234.05 ± 90.73), (445.36 ± 97.11) and (793.05 ± 121.03) μg/L, there was statistical difference ( F = 245.15, P<0.01). The results of receiver operating characteristic (ROC) curve analysis showed that when the cut-off value of serum sVCAM-1 level was 58.50 μg/L, the area under the curve (AUC) was 0.762 (95% CI 0.699 - 0.825, P<0.01), the sensitivity was 80.95%, the specificity was 67.50%, and the accuracy was 74.39%. Conclusions:The level of serum sVCAM-1 in MM patients is significantly increased, and the higher the level of SVCAM-1, the worse the prognosis of patients, which can be used as one of the indicator to predict the therapeutic effect of MM patients.

Objective:To analyze the clinical efficacy and learning curve for robot-assisted cortical bone trajectory (CBT) screw fixation performed by surgeons with different seniority in the treatment of lumbar degenerative disease.Methods:The clinical data of 91 lumbar degenerative disease patients underwent robot-assisted CBT screw fixation from August 2020 to December 2022 in Beijing Shijitan Hospital, Capital Medical University were retrospectively analyzed. Among them, 48 patients underwent surgery performed by the same senior surgeon (senior group), with a total of 234 CBT screws were placed; while 43 patients underwent surgery performed by the same junior surgeon (junior group), with a total of 206 CBT screws were placed. The surgical related indexes, functional improvement score, lower back pain and lower limb radiation pain scores, acceptable nail insertion rate, non invasion rate of facet joints and incidence of postoperative complications were compared between two groups. The functional improvement score was evaluated using the Japanese Orthopaedic Association (JOA) score, the pain score was evaluated using visual analog score (VAS). The cumulative sum (CUSUM) method was used to depict the learning curve with "single screw placement time" as the observation index.Results:There were no statistical difference in incision length, operation time, intraoperative blood loss and postoperative hospital stay between two groups ( P>0.05). The least squares means of JOA scores 1, 3 and 6 months after surgery in both groups increased significantly compared to baseline, while the least squares means of lower back pain VAS and lower limb radiation pain VAS decreased significantly compared to baseline; there were no statistical differences between two groups ( P>0.05). There were no statistical difference in acceptable nail insertion rate, non invasion rate of facet joints and incidence of postoperative complications between two group ( P>0.05). The CUSUM learning curves were fitting well and the inflection point for senior surgeon corresponded to 18 cases, while it was reached after performing surgery on 21 cases for junior surgeon. Conclusions:Robot-assisted CBT screw fixation performed by surgeons with different seniority could achieve similar clinical outcomes for treating lumbar degenerative disease. The senior surgeons are able to complete the initial learning stage faster than the junior surgeons, but there is not much difference in the number of surgeries performed the learning curve.

Objective:To evaluate the safety and efficacy of the TiRobot assisted screw placement in patients with lumbar degenerative diseases.Methods:The clinical data of 165 patients with lumbar degenerative diseases from January 2020 to December 2022 in Beijing Friendship Hospital, Capital Medical University were retrospectively analyze, and all patients were treated with posterior lumbar decompression and instrumentation. Among them, 46 patients were used the TiRobot assisted screw placement during surgery (robotic-assisted group), and 119 patients underwent freehand screw placement by C-arm X-ray machine fluoroscopy (freehand group). The operation time, intraoperative blood loss, complication and skelalgia visual analogue scale (VAS), Oswestry disability index (ODI) before and after operation were recorded. The accuracy of screw placement and rate of proximal facet joint violation were compared between two groups.Results:There were no statistical difference in operation time, intraoperative blood loss and incidence of complication between two groups ( P>0.05). In the two groups, the 3 d VAS and ODI after operation were significantly lower than those before operation, robot-assisted group: (3.33 ± 1.40) scores vs. (6.54 ± 2.00) scores and (16.96 ± 8.03) scores vs. (43.09 ± 5.48) scores; freehand group: (3.56 ± 1.29) scores vs. (6.55 ± 1.65) scores and (18.89 ± 6.74) scores vs. (44.91 ± 4.96) scores, and there were statistical differences ( P<0.01); there were no statistical difference in VAS and ODI before operation and 3 d after operation between two groups ( P>0.05). A total of 234 screws were implanted in robot-assisted group, and 590 screws were implanted in freehand group. The accuracy of screw placement in robot-assisted group was significantly higher than that in freehand group: 80.77% (189/234) vs. 74.58% (440/590), the rate of proximal facet joint violation was significantly lower than that in freehand group: 2.56% (6/234) vs. 7.29% (43/590), and there were statistical differences ( χ2 = 3.56 and 6.68, P<0.05). Conclusions:The TiRobot assisted screw placement for lumbar degenerative diseases is safe and effective. Compared to freehand technique, the TiRobot assisted method demonstrates higher screw placement accuracy and a lower rate of proximal facet joint violation.

Objective:To compare the effectiveness and safety between robot-assisted percutaneous kyphoplasty (PKP) and traditional fluoroscopy-assisted PKP in the treatment of dual-segment recurrent osteoporotic vertebral compression fracture (OVCF) including in situ vertebral fracture.Methods:The clinical data of 33 patients with dual-segment recurrent OVCF including in situ vertebral fracture from January 2016 to January 2023 in Beijing Shijitan Hospital Affiliated to Capital Medical University were retrospectively analyzed. All the patients were treated with PKP. Among them, 14 patients were treated with robot-assisted surgery (robot-assisted group), and 19 patients were treated with fluoroscopy-assisted surgery (fluoroscopy-assisted group). The total surgical time, preparation time and number of fluoroscopy were recorded. The in situ and other fracture vertebral operation time, number of punctures, amount of bone cement injection, bone cement filling effect, bone cement leakage, pedicle wall breakthrough and other special intraoperative situations were separately recorded. The visual analogue score (VAS) before surgery and 1 d, 3 months after surgery was recorded.Results:The preparation time in robot-assisted group was significantly longer than that in fluoroscopy-assisted group: (30.8 ± 6.9) min vs. (19.1 ± 4.5) min, the number of fluoroscopy was significantly lower than that in fluoroscopy-assisted group: (17.1 ± 4.1) times vs. (41.0 ± 6.3) times, and there were statistical differences ( P<0.01 and <0.05); there were no statistical differences in total surgical time and VAS at any time point between the two groups ( P>0.05). For the in situ fracture segment, the operation time and number of punctures in robot-assisted group were significantly lower than those in fluoroscopy-assisted group: (15.4 ± 2.8) min vs. (22.0 ± 5.5) min and (1.1 ± 0.4) times vs. (2.4 ± 1.2) times, the amount of bone cement injection was significantly higher than those in fluoroscopy-assisted group: (2.36 ± 0.75) ml vs. (1.79 ± 0.69) ml, the filling effect of bone cement was significantly better than that in fluoroscopy-assisted group, and there were statistical differences ( P<0.01 and <0.05); there were no statistical difference in bone cement leakage and pedicle wall breakthrough between the two groups ( P>0.05). For the other fracture segment, the operation time in robot-assisted group was significantly shorter than that in fluoroscopy-assisted group: (13.8 ± 3.8) min vs. (19.2 ± 6.4) min, and there was statistical difference ( P<0.01); there were no statistical difference in number of punctures, amount of bone cement injection, filling effect of bone cement, bone cement leakage and pedicle wall breakthrough between the two groups ( P>0.05). Conclusions:Robot-assisted PKP in the treatment of dual-segment OVCF including in situ vertebral fracture, could reduce operation time, minimize punctures and fluoroscopy numbers, and provide superior bone cement filling results.

Objective:To analyze the prognostic value of quantitative electroencephalography(EEG) monitoring combined with serum CXC chemokine 16 (CXCL16) and pentametin 3 (PTX3) in acute cerebral infarction.Methods:A total of 110 patients with acute cerebral infarction admitted to Jiangmen Central Hospital from March 2018 to March 2023 were retrospectively selected as the study objects, at 90 d after discharge, the prognosis of the patients was assessed by the modified Rankin Scale (mRs) score and divided into two groups, including 75 cases in the good prognosis group and 35 cases in the poor prognosis group. Quantitative EEG monitoring indexes and serum CXCL16 and PTX3 levels were compared between the two groups at admission. The receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficacy for poor prognosis in patients with acute cerebral infarction.Results:The levels of CXCL16 and PTX3 in the poor prognosis group were higher than those in the good prognosis group: (3.74 ± 0.59) μg/L vs. (2.58 ± 0.41) μg/L, (3.36 ± 0.67) μg/L vs. (3.01 ± 0.52) μg/L, there were statistical differences ( P<0.05). Compared with patients with good prognosis in acute cerebral infarction, the power ratio index (DTABR) level of the quantitative EEG monitoring index were higher than those in patients with a poor prognosis ( P<0.05). ROC curve analysis showed that the area under the curve of quantitative EEG monitoring combined with serum CXCL16, and PTX3 for predicting poor prognosis in patients with acute cerebral infarction was 0.911 (95% CI 0.849 - 0.974), which was higher than any single index ( P<0.05). Conclusions:The levels of DTABR, serum CXCL16 and PTX3 in patients with a poor prognosis of acute cerebral infarction were higher than those in patients with good prognosis. Quantitative EEG monitoring combined with serum CXCL16 and PTX3 had high predictive value for poor prognosis of acute cerebral infarction.

Objective:To analyze the risk factors of prognosis in patients with intracranial solitary fibrous tumor/hemangiopericytoma (SFT/HPC).Methods:The clinical data of 74 intracranial SFT/HPC patients underwent surgical treatment from January 2017 to January 2024 in Luhe Hospital, Capital Medical University and Sanbo Brain Hospital, Capital Medical University were retrospectively analyzed. The patients were followed up the prognosis (including recurrence, death and extracranial metastasis). Kaplan-Meier and log-rank tests were used to analyze the risk factors of prognosis in patients with intracranial SFT/HPC, and multivariate Cox analysis was used to analyze the independent risk factors of prognosis in patients with intracranial SFT/HPC.Results:Seventy-four patients with intracranial SFT/HPC were followed up for 3 to 80 months, averaging 52.5 months. Among them, there were 17 cases of recurrence, 6 cases of extracranial metastasis, and 12 cases of death. In patients with intracranial SFT/HPC, the results of the log-rank univariate analysis showed that the tumor location, resection extent, WHO pathological grade, and adjuvant radiotherapy were risk factors of recurrence ( P<0.01); the tumor location, WHO pathological grade and extracranial metastasis were risk factors of death ( P<0.05 or <0.01); and the age, WHO pathological grade and Ki67 were risk factors of extracranial metastasis ( P<0.05 or <0.01). In patients with intracranial SFT/HPC, multivariate Cox regression analysis result showed that the subtotal resection and non-postoperative radiation therapy were independent risk factors of recurrence ( HR = 0.377 and 0.315, 95% CI 0.148 to 0.932 and 0.164 to 2.221, P<0.01 and <0.05); the WHO pathological grade Ⅲ and extracranial metastasis were independent risk factors of death ( HR = 3.657 and 1.657, 95% CI 0.964 to 7.147 and 0.964 to 2.848, P<0.01); the WHO pathological grade Ⅲ was an independent risk factor of extracranial metastasis ( HR = 1.657, 95% CI 0.964 to 2.848, P<0.01). Conclusions:Patients with intracranial SFT/HPC who undergo subtotal resection and non-postoperative radiation therapy are more prone to recurrence, WHO pathological grade Ⅲ patients are more likely to develop extracranial metastases, and extracranial metastases patients have shorter survival. For intracranial SFT/HPC patients with pathologically high-grade, SFT/HPC, it is necessary to increase the frequency of follow-ups and be alert for extracranial metastasis.

Objective:To investigate the effects of lezumab adjuvant therapy on the degree of retinal vasculopathy and immune response in the treatment of macular central diabetic retinopathy (DR).Methods:From July 2022 to December 2023, 120 patients with DR in macular central who received treatment in the Xi′an People′s Hospital (Xi′an Fourth Hospital) were retrospectively selected and divided into two groups according to the treatment methods: the observation group (60 cases, lezumab combined with sitagliptin), and the control group (60 cases, sitagliptin). Patients′glucose metabolism, visual acuity, degree of retinopathy, inflammation [tumor necrosis factor-alpha (TNF-α), interleukin-2 (IL-2), interleukin-10 (IL-10)] and angiogenesis related factors [serum vascular endothelial growth factor (VEGF), midkine (MK), 5′-nucleotidase (CD73)] were evaluated, and the curative efficacy of the two groups was compared. The security of the two schemes was compared.Results:Compared with the control group, the serum concentrations of MK, CD73, TNF-α and VEGF were lower in the observation group after treatment: (1.44 ± 0.06) ng/L vs. (1.67 ± 0.11) ng/L, (1.10 ± 0.27) ng/L vs. (1.31 ± 0.26) ng/L, (11.62 ± 0.89) ng/L vs. (15.96 ± 4.42) ng/L, (84.07 ± 27.07) ng/L vs. (100.72 ± 16.05) ng/L, while the concentration of IL-10 was higher: (65.65 ± 8.68) ng/L vs. (60.02 ± 5.07) ng/L, with statistically significant differences ( P<0.05). There were no statistically significant differences in fasting blood glucose (FBG) and 2 h postprandial blood glucose between two groups before and after treatment ( P>0.05). After treatment, the macular thickness and visual field gray value in the observation group were lower than those in the control group: (302.81 ± 77.08) μm vs. (336.44 ± 10.35) μm, (1.55 ± 0.43)% vs. (2.09 ± 0.51)% ( P<0.05). After 3 months of treatment, the visual acuity in the observation group was higher than that in the control group: 0.493 ± 0.103 vs. 0.439 ± 0.084 ( P<0.05). No serious adverse reactions occurred in both groups. Conclusions:Lezumab assisted sitagliptin has a significant effect in the treatment of DR, which can reduce the degree of lesions, improve vision, and reduce the levels of inflammation and angiogenesis related factors.

Objective:To investigate the effect of ligation combined with peroral endoscopic cardial constriction (PECC) on the improvement of symptoms in patients with refractory gastroesophageal reflux disease(GERD).Methods:The clinical data of 42 patients with refractory GERD admitted to Zhejiang Zhoushan Hospital from March 2019 to March 2023 were collected retrospectively. Among them, 21 patients were treated with conventional drugs (control group), and 21 patients were treated with ligation combined with PECC on the basis of the control group(study group). The frequency and time of reflux, symptom score, frequency of reflux occurrence, and clinical efficacy of the two groups were compared before and after treatment.Results:After treatment, the longest regurgitation time, acid regurgitation time, total regurgitation times, acid regurgitation times, non-acid regurgitation times and weak acid regurgitation times in the study group were lower than those in the control group: (2.14 ± 0.12)min vs. (4.23 ± 1.03) min, (49.22 ± 5.13) min vs. (60.15 ± 6.21) min, (25.13 ± 2.11) times vs. (30.53 ± 3.52) times, (8.11 ± 0.63) times vs. (9.84 ± 0.85) times, (6.11 ± 0.51) times vs. (8.01 ± 0.72) times, (10.11 ± 1.12) times vs. (23.14 ± 1.29) times, there were statistical differences ( P<0.05). After treatment, the scores of GERD Health Quality of Life Scale (GERD-HRQL), Reflux Disease Questionnaire (RDQ) and Reflux Symptom Index Scale (RSI) in the study group were lower than those in the control group: (5.19 ± 0.42) scores vs. (11.34 ± 1.35) scores, (4.15 ± 0.34) scores vs. (10.66 ± 1.63) scores, (3.27 ± 0.24) scores vs.(7.51 ± 0.56) scores, there were statistical differences ( P<0.05). After treatment, the frequency of liquid-gas reflux, liquid reflux and gas reflux in the study group after treatment were lower than those in the control group: (10.14 ± 1.15) times/24 h vs. (14.39 ± 1.33) times/24 h, (5.12 ± 0.42) times/24 h vs. (6.06 ± 0.74) times/24 h, (7.62 ± 0.72) times/24 h vs. (10.43 ± 1.34) times/24 h, there were statistical differences ( P<0.05). The total effective rate in the study group was higher than that in the control group: 90.48%(19/21) vs. 57.14%(12/21), there was a statistical difference ( χ2 = 5.02, P<0.05). Conclusions:Ligation combined with PECC in patients with GERD has an ideal effect, which can effectively improve the frequency and symptom score of patients with reflux, reduce the frequency and time of reflux, and improve clinical efficacy.

Objective:To explore the prognosis and influencing factors of hepatocellular carcinoma patients with negative triple-biomarker after surgery.Methods:Two hundred patients undergoing surgeries for hepatocellular carcinoma with complete clinicopathological data from Lihuili Hospital Affiliated to Ningbo University from January 2020 to December 2021 were retrospectively analyzed, and their clinicopathological features, postoperative recurrence and prognosis were analyzed.Results:Among the 200 hepatocellular carcinoma patients, 54 cases were triple-negative type, 88 cases were protein induced by vitamin K absence-Ⅱ (PIVKA-Ⅱ) type, 51 cases were alpha-fetoprotein (AFP) type and 7 cases were alpha-fetoprotein Lens culinaris aggluyinin-reactive fraction 3 (AFP-L3) type. Due to the limited cases of AFP-L3 type, patients with this type were not included in this study. The recurrence rates were 29.6% (16/54), 40.9% (36/88) and 41.2% (21/51) for tripe-negative type, PIVKA-Ⅱ type and AFP type, respectively, the corresponding median recurrence-free survival time was 25.8, 10.6 and 10.0 months, respectively, and there were statistical differences ( P<0.05). The median overall survival time of tripe-negative type, PIVKA-Ⅱ type and AFP type was 40.7, 40.0 and 36.6 months, respectively, without statistical difference ( P>0.05). Univariate analysis showed that tumor diameter, tumor differentiation degree, and capsule or were not factors affecting patients′ overall survival time after surgery. Postoperative albumin, tumor diameter, tumor differentiation degree, capsule or not, and microvascular invasion were factors affecting patients′ recurrence-free survival time after surgery. Multivariate analysis showed that low tumor differentiation and no envelope were independent risk factors for patients′overall survival time after surgery. Tumor long diameter>5 cm, low differentiation, no envelope, preoperative hypoproteinemia and non-tripe-negative type were independent risk factors for patients′ recurrence-free survival time after surgery. Conclusions:The short-term postoperative recurrence rate for triple-negative hepatocellular carcinoma is low, and the correlation with long-term prognosis remains to be evaluated.